Chinese ‘Easter Eggs’ fall back to earth after wild year on Wall Street
Shares of Here Group, Zepp Health, Burning Rock Biotech and So-Young International all posted meteoric gains last year, but have given most of that back in 2026 Key Takeaways: A…
BRIEF: So-Young’s revenue rises 25% as self-operated clinics gain traction
Cosmetic surgery specialist So-Young International Inc. (SY.US) on Wednesday reported its revenue rose 25% year-on-year to 461 million yuan ($67 million) in the fourth quarter of last year, as the…
Can So-Young find new youth in bricks and mortar?
The cosmetic surgery specialist’s top line is growing as it opens new ‘light medical aesthetic’ clinics, but its bottom line is sagging as its older platform business evaporates Key Takeaways:…
So-Young rethinks reverse share split as its stock surges
The cosmetic surgery specialist’s shares have nearly doubled in the last two weeks as investors flock to its new business model centered on self-operated clinics Key Takeaways: So-Young has delayed…
BRIEF: Shanghai Chicmax’s profit surges nearly 70%, growth slows in second half
Cosmetics company Shanghai Chicmax Co. Ltd. (2145.HK) announced on Thursday its revenue rose 62.1% year-on-year to 6.79 billion yuan ($206 million) last year. Its net profit for the year increased…
So-Young dolls up with pivot to high-end services
The cosmetic services social media platform is developing its own clinics as well as a premium platform for high-end users Key Takeaways: So-Young reported an annual profit last year, reversing…
Regulatory Wrinkles Spoil So-Young’s Latest Results
Despite posting solid second-quarter growth, cosmetic surgery platform spends much of its earnings call trying to ease investor concerns over a regulatory crackdown Key takeaways: So-Young International devotes much of…
RELATED ARTICLES
-
U.S. tries ‘monkey scaring’ to rid Wall Street of suspicious Chinese listings
- What listings? Small Chinese firms withdraw their Wall Street IPO applications
-
Faded AI beauty: After superstar debut Nuobikan falls back to earth
2635.HK
- Chinese medicine firm seeks elusive elixir of IPO success
-
Tongcheng’s rosy report fails to discuss the worrisome elephant in its house
0780.HK
